Description of a national, multi‐center registry of patients with sickle cell disease and SARS‐CoV‐2 infection: Data from the Pediatric COVID‐19 United States Registry

Documents similaires

• Clinical Outcomes of Respiratory Syncytial Virus Infection Among Pediatric Immunocompromised Hosts
  par: Hailey S. Ross, et autres
  Publié: (2024)
• Reply to: Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
  par: Jennifer Longoria, et autres
  Publié: (2024)
• Pediatric and Adolescent Cancer Incidence Rates in 29 Non‐Metropolitan US Counties: An Analysis of Publicly Available Data
  par: Ingrid Jacobson, et autres
  Publié: (2026)
• Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series
  par: Ajibike Lapite, et autres
  Publié: (2024)
• Assessing Acute and Long‐Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry
  par: Jamil Almohtasib, et autres
  Publié: (2025)